Loading…

Melatonin changes energy metabolism and reduces oncogenic signaling in ovarian cancer cells

Ovarian cancer (OC) adjusts energy metabolism in favor of its progression and dissemination. Because melatonin (Mel) has antitumor actions, we investigated its impact on energy metabolism and kinase signaling in OC cells (SKOV-3 and CAISMOV-24). Cells were divided into control and Mel-treated groups...

Full description

Saved in:
Bibliographic Details
Published in:Molecular and cellular endocrinology 2024-10, Vol.592, p.112296, Article 112296
Main Authors: Silveira, Henrique Spaulonci, Cesário, Roberta Carvalho, Vígaro, Renan Aparecido, Gaiotte, Leticia Barbosa, Cucielo, Maira Smaniotto, Guimarães, Fernando, Seiva, Fábio Rodrigues Ferreira, Zuccari, Debora Aparecida P.C., Reiter, Russel J., Chuffa, Luiz Gustavo de Almeida
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c235t-3ac4840d823fd63ba63811cc5d00a86b0e0b675803d7bff673b297e86047cfbf3
container_end_page
container_issue
container_start_page 112296
container_title Molecular and cellular endocrinology
container_volume 592
creator Silveira, Henrique Spaulonci
Cesário, Roberta Carvalho
Vígaro, Renan Aparecido
Gaiotte, Leticia Barbosa
Cucielo, Maira Smaniotto
Guimarães, Fernando
Seiva, Fábio Rodrigues Ferreira
Zuccari, Debora Aparecida P.C.
Reiter, Russel J.
Chuffa, Luiz Gustavo de Almeida
description Ovarian cancer (OC) adjusts energy metabolism in favor of its progression and dissemination. Because melatonin (Mel) has antitumor actions, we investigated its impact on energy metabolism and kinase signaling in OC cells (SKOV-3 and CAISMOV-24). Cells were divided into control and Mel-treated groups, in the presence or absence of the antagonist luzindole. There was a decrease in the levels of HIF-1α, G6PDH, GAPDH, PDH, and CS after Mel treatment even in the presence of luzindole in both OC cells. Mel treatment also reduced the activity of OC-related enzymes including PFK-1, G6PDH, LDH, CS, and GS whereas PDH activity was increased. Lactate and glutamine levels dropped after Mel treatment. Mel further promoted a reduction in the concentrations of CREB, JNK, NF-kB, p-38, ERK1/2, AKT, P70S6K, and STAT in both cell lines. Mel reverses Warburg-type metabolism and possibly reduces glutaminolysis, thereby attenuating various oncogenic molecules associated with OC progression and invasion. [Display omitted] •Melatonin reduces glycolysis and increases pyruvate dehydrogenase activity in OC cells.•Ovarian cancer metabolism-related enzyme activities were altered by melatonin.•Melatonin has a broad impact on reducing key molecules associated with OC progression.•Melatonin reverses Warburg-type metabolism of OC cells in the presence of luzindole.
doi_str_mv 10.1016/j.mce.2024.112296
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3065980883</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0303720724001527</els_id><sourcerecordid>3065980883</sourcerecordid><originalsourceid>FETCH-LOGICAL-c235t-3ac4840d823fd63ba63811cc5d00a86b0e0b675803d7bff673b297e86047cfbf3</originalsourceid><addsrcrecordid>eNp9kLFu2zAQhokiQe2kfYAugcYsco-kRFLoVARpUyBFl2TKQFDkSaUhkQ4pB_Dbl4bTjJluuO__cfcR8oXChgIVX7eb2eKGAWs2lDLWiQ9kTZVktYJWnpE1cOC1ZCBX5CLnLQDIlqmPZMWVahroxJo8_cbJLDH4UNm_JoyYKwyYxkM142L6OPk8Vya4KqHb27KNwcYRg7dV9mMwkw9jVcLxxSRvSokJFlNlcZryJ3I-mCnj59d5SR5_3D7c3NX3f37-uvl-X1vG26XmxjaqAacYH5zgvRFcUWpt6wCMEj0g9EK2CriT_TAIyXvWSVQCGmmHfuCX5PrUu0vxeY950bPPxwtMwLjPmoNoOwVK8YLSE2pTzDnhoHfJzyYdNAV9dKq3ujjVR6f65LRkrl7r9_2M7i3xX2IBvp0ALE--eEw6W4_Fg_MJ7aJd9O_U_wPm_Ieb</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3065980883</pqid></control><display><type>article</type><title>Melatonin changes energy metabolism and reduces oncogenic signaling in ovarian cancer cells</title><source>ScienceDirect Journals</source><creator>Silveira, Henrique Spaulonci ; Cesário, Roberta Carvalho ; Vígaro, Renan Aparecido ; Gaiotte, Leticia Barbosa ; Cucielo, Maira Smaniotto ; Guimarães, Fernando ; Seiva, Fábio Rodrigues Ferreira ; Zuccari, Debora Aparecida P.C. ; Reiter, Russel J. ; Chuffa, Luiz Gustavo de Almeida</creator><creatorcontrib>Silveira, Henrique Spaulonci ; Cesário, Roberta Carvalho ; Vígaro, Renan Aparecido ; Gaiotte, Leticia Barbosa ; Cucielo, Maira Smaniotto ; Guimarães, Fernando ; Seiva, Fábio Rodrigues Ferreira ; Zuccari, Debora Aparecida P.C. ; Reiter, Russel J. ; Chuffa, Luiz Gustavo de Almeida</creatorcontrib><description>Ovarian cancer (OC) adjusts energy metabolism in favor of its progression and dissemination. Because melatonin (Mel) has antitumor actions, we investigated its impact on energy metabolism and kinase signaling in OC cells (SKOV-3 and CAISMOV-24). Cells were divided into control and Mel-treated groups, in the presence or absence of the antagonist luzindole. There was a decrease in the levels of HIF-1α, G6PDH, GAPDH, PDH, and CS after Mel treatment even in the presence of luzindole in both OC cells. Mel treatment also reduced the activity of OC-related enzymes including PFK-1, G6PDH, LDH, CS, and GS whereas PDH activity was increased. Lactate and glutamine levels dropped after Mel treatment. Mel further promoted a reduction in the concentrations of CREB, JNK, NF-kB, p-38, ERK1/2, AKT, P70S6K, and STAT in both cell lines. Mel reverses Warburg-type metabolism and possibly reduces glutaminolysis, thereby attenuating various oncogenic molecules associated with OC progression and invasion. [Display omitted] •Melatonin reduces glycolysis and increases pyruvate dehydrogenase activity in OC cells.•Ovarian cancer metabolism-related enzyme activities were altered by melatonin.•Melatonin has a broad impact on reducing key molecules associated with OC progression.•Melatonin reverses Warburg-type metabolism of OC cells in the presence of luzindole.</description><identifier>ISSN: 0303-7207</identifier><identifier>ISSN: 1872-8057</identifier><identifier>EISSN: 1872-8057</identifier><identifier>DOI: 10.1016/j.mce.2024.112296</identifier><identifier>PMID: 38844096</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Cellular metabolism ; Glutaminolysis ; Kinase signaling ; Melatonin ; Ovarian cancer ; Tumor progression ; Warburg effect</subject><ispartof>Molecular and cellular endocrinology, 2024-10, Vol.592, p.112296, Article 112296</ispartof><rights>2024 Elsevier B.V.</rights><rights>Copyright © 2024. Published by Elsevier B.V.</rights><rights>Copyright © 2024 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c235t-3ac4840d823fd63ba63811cc5d00a86b0e0b675803d7bff673b297e86047cfbf3</cites><orcidid>0000-0002-7461-8773 ; 0000-0002-0199-3396 ; 0000-0002-5537-972X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38844096$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Silveira, Henrique Spaulonci</creatorcontrib><creatorcontrib>Cesário, Roberta Carvalho</creatorcontrib><creatorcontrib>Vígaro, Renan Aparecido</creatorcontrib><creatorcontrib>Gaiotte, Leticia Barbosa</creatorcontrib><creatorcontrib>Cucielo, Maira Smaniotto</creatorcontrib><creatorcontrib>Guimarães, Fernando</creatorcontrib><creatorcontrib>Seiva, Fábio Rodrigues Ferreira</creatorcontrib><creatorcontrib>Zuccari, Debora Aparecida P.C.</creatorcontrib><creatorcontrib>Reiter, Russel J.</creatorcontrib><creatorcontrib>Chuffa, Luiz Gustavo de Almeida</creatorcontrib><title>Melatonin changes energy metabolism and reduces oncogenic signaling in ovarian cancer cells</title><title>Molecular and cellular endocrinology</title><addtitle>Mol Cell Endocrinol</addtitle><description>Ovarian cancer (OC) adjusts energy metabolism in favor of its progression and dissemination. Because melatonin (Mel) has antitumor actions, we investigated its impact on energy metabolism and kinase signaling in OC cells (SKOV-3 and CAISMOV-24). Cells were divided into control and Mel-treated groups, in the presence or absence of the antagonist luzindole. There was a decrease in the levels of HIF-1α, G6PDH, GAPDH, PDH, and CS after Mel treatment even in the presence of luzindole in both OC cells. Mel treatment also reduced the activity of OC-related enzymes including PFK-1, G6PDH, LDH, CS, and GS whereas PDH activity was increased. Lactate and glutamine levels dropped after Mel treatment. Mel further promoted a reduction in the concentrations of CREB, JNK, NF-kB, p-38, ERK1/2, AKT, P70S6K, and STAT in both cell lines. Mel reverses Warburg-type metabolism and possibly reduces glutaminolysis, thereby attenuating various oncogenic molecules associated with OC progression and invasion. [Display omitted] •Melatonin reduces glycolysis and increases pyruvate dehydrogenase activity in OC cells.•Ovarian cancer metabolism-related enzyme activities were altered by melatonin.•Melatonin has a broad impact on reducing key molecules associated with OC progression.•Melatonin reverses Warburg-type metabolism of OC cells in the presence of luzindole.</description><subject>Cellular metabolism</subject><subject>Glutaminolysis</subject><subject>Kinase signaling</subject><subject>Melatonin</subject><subject>Ovarian cancer</subject><subject>Tumor progression</subject><subject>Warburg effect</subject><issn>0303-7207</issn><issn>1872-8057</issn><issn>1872-8057</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kLFu2zAQhokiQe2kfYAugcYsco-kRFLoVARpUyBFl2TKQFDkSaUhkQ4pB_Dbl4bTjJluuO__cfcR8oXChgIVX7eb2eKGAWs2lDLWiQ9kTZVktYJWnpE1cOC1ZCBX5CLnLQDIlqmPZMWVahroxJo8_cbJLDH4UNm_JoyYKwyYxkM142L6OPk8Vya4KqHb27KNwcYRg7dV9mMwkw9jVcLxxSRvSokJFlNlcZryJ3I-mCnj59d5SR5_3D7c3NX3f37-uvl-X1vG26XmxjaqAacYH5zgvRFcUWpt6wCMEj0g9EK2CriT_TAIyXvWSVQCGmmHfuCX5PrUu0vxeY950bPPxwtMwLjPmoNoOwVK8YLSE2pTzDnhoHfJzyYdNAV9dKq3ujjVR6f65LRkrl7r9_2M7i3xX2IBvp0ALE--eEw6W4_Fg_MJ7aJd9O_U_wPm_Ieb</recordid><startdate>20241001</startdate><enddate>20241001</enddate><creator>Silveira, Henrique Spaulonci</creator><creator>Cesário, Roberta Carvalho</creator><creator>Vígaro, Renan Aparecido</creator><creator>Gaiotte, Leticia Barbosa</creator><creator>Cucielo, Maira Smaniotto</creator><creator>Guimarães, Fernando</creator><creator>Seiva, Fábio Rodrigues Ferreira</creator><creator>Zuccari, Debora Aparecida P.C.</creator><creator>Reiter, Russel J.</creator><creator>Chuffa, Luiz Gustavo de Almeida</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7461-8773</orcidid><orcidid>https://orcid.org/0000-0002-0199-3396</orcidid><orcidid>https://orcid.org/0000-0002-5537-972X</orcidid></search><sort><creationdate>20241001</creationdate><title>Melatonin changes energy metabolism and reduces oncogenic signaling in ovarian cancer cells</title><author>Silveira, Henrique Spaulonci ; Cesário, Roberta Carvalho ; Vígaro, Renan Aparecido ; Gaiotte, Leticia Barbosa ; Cucielo, Maira Smaniotto ; Guimarães, Fernando ; Seiva, Fábio Rodrigues Ferreira ; Zuccari, Debora Aparecida P.C. ; Reiter, Russel J. ; Chuffa, Luiz Gustavo de Almeida</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c235t-3ac4840d823fd63ba63811cc5d00a86b0e0b675803d7bff673b297e86047cfbf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Cellular metabolism</topic><topic>Glutaminolysis</topic><topic>Kinase signaling</topic><topic>Melatonin</topic><topic>Ovarian cancer</topic><topic>Tumor progression</topic><topic>Warburg effect</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Silveira, Henrique Spaulonci</creatorcontrib><creatorcontrib>Cesário, Roberta Carvalho</creatorcontrib><creatorcontrib>Vígaro, Renan Aparecido</creatorcontrib><creatorcontrib>Gaiotte, Leticia Barbosa</creatorcontrib><creatorcontrib>Cucielo, Maira Smaniotto</creatorcontrib><creatorcontrib>Guimarães, Fernando</creatorcontrib><creatorcontrib>Seiva, Fábio Rodrigues Ferreira</creatorcontrib><creatorcontrib>Zuccari, Debora Aparecida P.C.</creatorcontrib><creatorcontrib>Reiter, Russel J.</creatorcontrib><creatorcontrib>Chuffa, Luiz Gustavo de Almeida</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Molecular and cellular endocrinology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Silveira, Henrique Spaulonci</au><au>Cesário, Roberta Carvalho</au><au>Vígaro, Renan Aparecido</au><au>Gaiotte, Leticia Barbosa</au><au>Cucielo, Maira Smaniotto</au><au>Guimarães, Fernando</au><au>Seiva, Fábio Rodrigues Ferreira</au><au>Zuccari, Debora Aparecida P.C.</au><au>Reiter, Russel J.</au><au>Chuffa, Luiz Gustavo de Almeida</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Melatonin changes energy metabolism and reduces oncogenic signaling in ovarian cancer cells</atitle><jtitle>Molecular and cellular endocrinology</jtitle><addtitle>Mol Cell Endocrinol</addtitle><date>2024-10-01</date><risdate>2024</risdate><volume>592</volume><spage>112296</spage><pages>112296-</pages><artnum>112296</artnum><issn>0303-7207</issn><issn>1872-8057</issn><eissn>1872-8057</eissn><abstract>Ovarian cancer (OC) adjusts energy metabolism in favor of its progression and dissemination. Because melatonin (Mel) has antitumor actions, we investigated its impact on energy metabolism and kinase signaling in OC cells (SKOV-3 and CAISMOV-24). Cells were divided into control and Mel-treated groups, in the presence or absence of the antagonist luzindole. There was a decrease in the levels of HIF-1α, G6PDH, GAPDH, PDH, and CS after Mel treatment even in the presence of luzindole in both OC cells. Mel treatment also reduced the activity of OC-related enzymes including PFK-1, G6PDH, LDH, CS, and GS whereas PDH activity was increased. Lactate and glutamine levels dropped after Mel treatment. Mel further promoted a reduction in the concentrations of CREB, JNK, NF-kB, p-38, ERK1/2, AKT, P70S6K, and STAT in both cell lines. Mel reverses Warburg-type metabolism and possibly reduces glutaminolysis, thereby attenuating various oncogenic molecules associated with OC progression and invasion. [Display omitted] •Melatonin reduces glycolysis and increases pyruvate dehydrogenase activity in OC cells.•Ovarian cancer metabolism-related enzyme activities were altered by melatonin.•Melatonin has a broad impact on reducing key molecules associated with OC progression.•Melatonin reverses Warburg-type metabolism of OC cells in the presence of luzindole.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>38844096</pmid><doi>10.1016/j.mce.2024.112296</doi><orcidid>https://orcid.org/0000-0002-7461-8773</orcidid><orcidid>https://orcid.org/0000-0002-0199-3396</orcidid><orcidid>https://orcid.org/0000-0002-5537-972X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0303-7207
ispartof Molecular and cellular endocrinology, 2024-10, Vol.592, p.112296, Article 112296
issn 0303-7207
1872-8057
1872-8057
language eng
recordid cdi_proquest_miscellaneous_3065980883
source ScienceDirect Journals
subjects Cellular metabolism
Glutaminolysis
Kinase signaling
Melatonin
Ovarian cancer
Tumor progression
Warburg effect
title Melatonin changes energy metabolism and reduces oncogenic signaling in ovarian cancer cells
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T20%3A28%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Melatonin%20changes%20energy%20metabolism%20and%20reduces%20oncogenic%20signaling%20in%20ovarian%20cancer%20cells&rft.jtitle=Molecular%20and%20cellular%20endocrinology&rft.au=Silveira,%20Henrique%20Spaulonci&rft.date=2024-10-01&rft.volume=592&rft.spage=112296&rft.pages=112296-&rft.artnum=112296&rft.issn=0303-7207&rft.eissn=1872-8057&rft_id=info:doi/10.1016/j.mce.2024.112296&rft_dat=%3Cproquest_cross%3E3065980883%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c235t-3ac4840d823fd63ba63811cc5d00a86b0e0b675803d7bff673b297e86047cfbf3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3065980883&rft_id=info:pmid/38844096&rfr_iscdi=true